Latest AI and machine learning research in fda general for healthcare professionals.
Drug discovery is a complex and resource-intensive process, making early prediction of approval outc...
The deployment of artificial intelligence (AI) translation tools in healthcare is accelerating rapid...
INTRODUCTION: Soft robotic gloves (SRGs) integrated with brain-computer interfaces (BCIs) have demon...
Counterfeit and substandard pharmaceuticals represent a critical global health crisis, with the Worl...
Diabetes mellitus (DM) is a growing global health challenge, particularly in low-resource settings w...
AIMS/INTRODUCTION: Severe hypoglycemia (SH) is a major complication in adults with type 1 diabetes m...
Cell lines are essential tools for studying biological mechanisms, advancing pre-clinical drug disco...
Triple-negative breast cancer occurs as a formidable challenge in cancer research due to the charact...
OBJECTIVES: To evaluate intratumoral subregional and peritumoral radiomics for predicting pathologic...
AIMS: Ultrasound is a highly sensitive method to detect developmental dysplasia of the hip (DDH). Ho...
BACKGROUND: Parkinson's disease (PD) is a common neurodegenerative disorder characterised by high pr...
OBJECTIVE: Antiphospholipid syndrome (APS) is a thromboinflammatory disorder characterized by clinic...
For rapid real-time detection of veterinary drug residues in paddy field water, we developed a novel...
Manufacturing processes involve various inspections aimed at identifying faulty products before they...
INTRODUCTION: Pulmonary embolism (PE) is a potentially fatal condition requiring timely diagnosis an...
INTRODUCTION: High costs of screening and diagnostic tests remain a major barrier to timely tubercul...
BACKGROUND: Psychological distress, particularly symptoms of depression and anxiety (D&A), is highly...
Background: Transcranial magnetic stimulation (TMS) is an FDA-cleared neuromodulation technique with...
Phase separation (PS) underpins compartmentalization in living cells, facilitating the formation of ...
Prussian blue nanoparticles (PBNPs) are a versatile platform for administering photothermal therapy ...
Alzheimer's disease (AD) requires the discovery of new therapeutic targets, but traditional molecula...